Hypertension

Papers
(The H4-Index of Hypertension is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
2020 International Society of Hypertension Global Hypertension Practice Guidelines1887
Renin-Angiotensin System Blockers and the COVID-19 Pandemic365
Age and Multimorbidity Predict Death Among COVID-19 Patients306
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension239
Blood Pressure and Risks of Cognitive Impairment and Dementia177
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension176
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association169
May Measurement Month 2019159
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor140
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary139
Trimethylamine-N-Oxide Promotes Age-Related Vascular Oxidative Stress and Endothelial Dysfunction in Mice and Healthy Humans135
Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018132
Management of Hypertension in the Digital Era125
Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness119
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension114
Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19110
Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension104
Early and Supernormal Vascular Aging101
Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension100
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease99
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic96
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association95
Discrimination and Hypertension Risk Among African Americans in the Jackson Heart Study93
Antihypertensive Drugs and COVID-19 Risk93
Evaluation of the Accuracy of Cuffless Blood Pressure Measurement Devices: Challenges and Proposals92
Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine81
Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association78
Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Hypertension78
Urate, Blood Pressure, and Cardiovascular Disease77
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 202071
Microbial Peer Pressure68
Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease68
Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia67
Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure67
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients67
Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk66
Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study66
Epithelial Sodium Channel and Salt-Sensitive Hypertension65
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk64
COVID-1964
Influence of Sex and Age on Muscle Sympathetic Nerve Activity of Healthy Normotensive Adults62
Animal Models of Preeclampsia60
Gnotobiotic Rats Reveal That Gut Microbiota Regulates Colonic mRNA of Ace2 , the Receptor for SARS-CoV-2 Infectivity60
Blood Pressure and Risk of Cardiovascular Disease in UK Biobank60
Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives60
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases59
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study59
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 Vaccination58
Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association58
Visit-to-Visit Blood Pressure Variability Is Associated With Cognitive Decline and Incident Dementia57
Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension57
Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated With Pharmacological Blockers of the Renin-Angiotensin System57
Impact of the Vulnerable Preterm Heart and Circulation on Adult Cardiovascular Disease Risk56
Pulmonary Hypertension Due to Left Heart Disease56
Hypertension, Prehypertension, and Hypertension Control56
Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses56
0.042428016662598